BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 3174583)

  • 1. [Anti-elastolytic inhibitory capacity and IgA deficiency--contribution to the etiopathogenesis of COPD].
    Schultek T; Braun J; Wood WG; Wiessmann KJ
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():307-8. PubMed ID: 3174583
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibitor activity against elastolytic enzymes in the bronchial area. A contribution to the pathogenesis of chronic airway obstruction.
    Rasche B
    Z Erkr Atmungsorgane; 1985; 165(1):83-93. PubMed ID: 3851611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Elastase and elastase inhibitors in bronchial mucus in chronic airway obstruction with reference to therapy].
    Rasche B; Hochstrasser K
    Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():725-7. PubMed ID: 6557570
    [No Abstract]   [Full Text] [Related]  

  • 4. The pathogenesis of chronic obstructive lung diseases: implications for therapy.
    Stockley RA
    QJM; 1995 Feb; 88(2):141-6. PubMed ID: 7704565
    [No Abstract]   [Full Text] [Related]  

  • 5. [Changes of neutrophil elastase in COPD and the role of elastase in experimental pulmonary hypertension].
    Yan YZ
    Zhonghua Jie He He Hu Xi Za Zhi; 1988 Dec; 11(6):324-6, 384. PubMed ID: 3250749
    [No Abstract]   [Full Text] [Related]  

  • 6. Electrophoretic mobility of leukocyte elastase of normal subjects and patients with chronic obstructive pulmonary disease.
    Taylor JC; Kueppers F
    Am Rev Respir Dis; 1977 Sep; 116(3):531-6. PubMed ID: 409318
    [No Abstract]   [Full Text] [Related]  

  • 7. Bronchitis in patients with hypogammaglobulinemia and other immunodeficiencies.
    Björkander J; Bake B; Hanson LA
    Eur J Respir Dis Suppl; 1982; 118():97-9. PubMed ID: 6954104
    [No Abstract]   [Full Text] [Related]  

  • 8. [Bronchopulmonary infections and total selective IgA deficiency].
    Dalmasso F; Sirkka M; Torchio R; Neretto G
    Arch Monaldi; 1982; 37(3-4):171-80. PubMed ID: 7187736
    [No Abstract]   [Full Text] [Related]  

  • 9. Substituted 2-pyrones, 2-pyridones, and other congeners of elasnin as potential agents for the treatment of chronic obstructive lung diseases.
    Groutas WC; Stanga MA; Brubaker MJ; Huang TL; Moi MK; Carroll RT
    J Med Chem; 1985 Aug; 28(8):1106-9. PubMed ID: 3848491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fibromyalgia syndrome with IgA and IgG subclass deficiency].
    Riederer J
    Med Klin (Munich); 1991 Oct; 86(10):547-9. PubMed ID: 1758378
    [No Abstract]   [Full Text] [Related]  

  • 11. [Substitutive therapy with immunoglobulin in total selective IgA deficiency].
    Dalmasso F; Guarene MM; Sirkka M; Capaldi S
    Arch Monaldi; 1982; 37(3-4):181-90. PubMed ID: 7187737
    [No Abstract]   [Full Text] [Related]  

  • 12. The pallid mouse. A model of genetic alpha 1-antitrypsin deficiency.
    Martorana PA; Brand T; Gardi C; van Even P; de Santi MM; Calzoni P; Marcolongo P; Lungarella G
    Lab Invest; 1993 Feb; 68(2):233-41. PubMed ID: 8441253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Elastase activity of the sputum and the functional activity of serum alpha 1-antitrypsin in patients with chronic obstructive pulmonary disease].
    Zhou SW
    Zhonghua Jie He He Hu Xi Za Zhi; 1988 Oct; 11(5):269-70, 318. PubMed ID: 3266105
    [No Abstract]   [Full Text] [Related]  

  • 14. The immune system in isolated IgA deficiency.
    Melamed I; Zakuth V; Kark JO; Spirer Z
    J Clin Lab Immunol; 1985 Aug; 17(4):163-6. PubMed ID: 3877811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of different elastase inhibitors on leukocyte elastase pre-adsorbed to elastin.
    Hornebeck W; Schnebli HP
    Hoppe Seylers Z Physiol Chem; 1982 Apr; 363(4):455-8. PubMed ID: 6918355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strongyloidiasis in a patient with IgA deficiency.
    Leung VK; Liew CT; Sung JJ
    Trop Gastroenterol; 1995; 16(4):27-30. PubMed ID: 8854952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elastase-type activity of human serum. Its variation in chronic obstructive lung diseases and atherosclerosis.
    Hornebeck W; Potazman JP; De Cremoux H; Bellon G; Robert L
    Clin Physiol Biochem; 1983; 1(6):285-92. PubMed ID: 6568131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Elastase and the anti-elastase activity of blood and its possible relation to the pathogenesis of aterosclerosis. Elastolytic enzymes].
    Cammarota H; Cuatrecasas J; Yaconis L
    Prensa Med Argent; 1968 Jul; 55(22):1040-4. PubMed ID: 5728689
    [No Abstract]   [Full Text] [Related]  

  • 19. The elastase: anti-elastase profile in lung lavage from sarcoidosis patients.
    Smith SF; Guz A; Burton GH; Heaton R; Cooke NT; Tetley TD
    Sarcoidosis; 1988 Mar; 5(1):31-7. PubMed ID: 3381016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel potential mechanism-based inhibitors of human leukocyte elastase and cathepsin G: derivatives of isothiazolidin-3-one.
    Groutas WC; Chong LS; Venkataraman R
    Biochem Biophys Res Commun; 1993 Dec; 197(2):730-9. PubMed ID: 8267609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.